Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells

被引:19
作者
Masala, Erico [1 ]
Valencia, Ana [1 ]
Buchi, Francesca [1 ]
Nosi, Daniele [2 ]
Spinelli, Elena [1 ]
Gozzini, Antonella [1 ]
Sassolini, Francesca [1 ]
Sanna, Alessandro [1 ]
Zecchi, Sandra [2 ]
Bosi, Alberto [1 ]
Santini, Valeria [1 ]
机构
[1] Univ Florence, Funct Unit Haematol, AOU Careggi, I-50134 Florence, Italy
[2] Univ Florence, Dept Human Anat, I-50134 Florence, Italy
关键词
MDS; Methylation; Wnt pathway; Wnt antagonists; beta-Catenin; Azacitidine; ACUTE MYELOID-LEUKEMIA; SIGNALING PATHWAY; METHYLATION; MDS;
D O I
10.1016/j.leukres.2012.05.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We observed aberrant gene methylation of Wnt antagonists: sFRP1, sFRP2, sFRP4, sFRP5 and DKK1 in marrow cells of 55 MDS cases. Methylation of Wnt antagonist genes was associated with activation of the Wnt signaling pathway, consistent with the up-regulation of the Wnt downstream genes TCF1 and LEF1. Azacitidine exposure induced demethylation of Wnt-antagonist gene promoters and reduction of the non-phosphorylated beta-catenin (NPBC) which is prevalent during Wnt pathway inactivation. Presence of >= 5% of bone marrow blasts was associated with methylation of sFRP1 and DKK1 and with methylation of more than two of the five Wnt antagonist genes. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1290 / 1295
页数:6
相关论文
共 50 条
  • [31] Activation of non-canonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate determination of human bone marrow stromal (mesenchymal) stem cells
    Qiu, Weimin
    Chen, Li
    Kassem, Moustapha
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 413 (01) : 98 - 104
  • [32] Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells
    Asciutti, S.
    Akiri, G.
    Grumolato, L.
    Vijayakumar, S.
    Aaronson, S. A.
    ONCOGENE, 2011, 30 (08) : 956 - 966
  • [33] Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation
    Schweigert, Amei
    Fischer, Carmen
    Mayr, Doris
    von Schweinitz, Dietrich
    Kappler, Roland
    Hubertus, Jochen
    PEDIATRIC SURGERY INTERNATIONAL, 2016, 32 (12) : 1141 - 1146
  • [34] Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway
    Fuerer, C
    Iggo, R
    GENE THERAPY, 2002, 9 (04) : 270 - 281
  • [35] Gene variants for the WNT pathway are associated with severity in periodontal disease
    Ospina-Ch, Maria-Victoria
    Acevedo-Godoy, Monica
    Perdomo, Sandra J.
    Chila-Moreno, Lorena
    Lafaurie, Gloria I.
    Romero-Sanchez, Consuelo
    CLINICAL ORAL INVESTIGATIONS, 2024, 28 (02)
  • [36] Wnt and Hedgehog Gene Pathway Expression in Serous Ovarian Cancer
    Schmid, Seraina
    Bieber, Marcia
    Zhang, Fang
    Zhang, Mallory
    He, Biao
    Jablons, David
    Teng, Nelson N. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (06) : 975 - 980
  • [37] Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer
    Guo, Yongli
    Wang, Meng
    Jia, Xuefeng
    Zhu, Hua
    Zhi, Yaqin
    Yuan, Leilei
    ONCOLOGY REPORTS, 2018, 40 (02) : 1165 - 1173
  • [38] Activation of the canonical Wnt/β-catenin pathway enhances monocyte adhesion to endothelial cells
    Lee, Dong Kun
    Grantham, R. Nathan
    Trachte, Aaron L.
    Mannion, John D.
    Wilson, Colleen L.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 347 (01) : 109 - 116
  • [39] Potential Function of Exogenous Vimentin on the Activation of Wnt Signaling Pathway in Cancer Cells
    Satelli, Arun
    Hu, Jiemiao
    Xia, Xueqing
    Li, Shulin
    JOURNAL OF CANCER, 2016, 7 (13): : 1824 - 1832
  • [40] Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway
    C Fuerer
    R Iggo
    Gene Therapy, 2002, 9 : 270 - 281